Cargando…

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer

SIMPLE SUMMARY: The uPA/uPAR system is highly involved in cancer progression and metastasis. Many studies have definitively assessed that the high expression of urokinase-type plasminogen activator (uPA) and membrane urokinase-type plasminogen activator receptor (uPAR) in patients does correlate wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masucci, Maria Teresa, Minopoli, Michele, Di Carluccio, Gioconda, Motti, Maria Letizia, Carriero, Maria Vincenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833673/ https://www.ncbi.nlm.nih.gov/pubmed/35158766 http://dx.doi.org/10.3390/cancers14030498

Ejemplares similares

Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
por: Masucci, Maria Teresa, et al.
Publicado: (2023)

Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
por: Yousif, Ali Munaim, et al.
Publicado: (2015)

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors
por: Motti, Maria Letizia, et al.
Publicado: (2020)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion
por: Bifulco, Katia, et al.
Publicado: (2012)

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
por: Ragone, Concetta, et al.
Publicado: (2017)

Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
por: Bifulco, Katia, et al.
Publicado: (2014)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017)

Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
por: Masucci, Maria Teresa, et al.
Publicado: (2019)

The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
por: Ingangi, Vincenzo, et al.
Publicado: (2016)

Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
por: Ingangi, Vincenzo, et al.
Publicado: (2019)

The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis
por: Masucci, Maria Teresa, et al.
Publicado: (2020)

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity
por: Minopoli, Michele, et al.
Publicado: (2019)

Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
por: Minopoli, Michele, et al.
Publicado: (2019)

Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development
por: Fratangelo, Federica, et al.
Publicado: (2018)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
por: Fratangelo, Federica, et al.
Publicado: (2018)

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma
por: Minopoli, Michele, et al.
Publicado: (2020)

Effects of S-adenosyl-L-methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms
por: Mosca, Laura, et al.
Publicado: (2020)

The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19)
por: Motti, Maria Letizia, et al.
Publicado: (2022)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
por: Zhai, Bing-Tao, et al.
Publicado: (2022)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

The Urokinase/Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
por: Rossi, Francesca Wanda, et al.
Publicado: (2016)

Urokinase receptor and resistance to targeted anticancer agents
por: Gonias, Steven L., et al.
Publicado: (2015)

Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer
por: Montuori, Nunzia, et al.
Publicado: (2016)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
por: Li Santi, Anna, et al.
Publicado: (2021)

p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors
por: Maietta, Immacolata, et al.
Publicado: (2022)

The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
por: Kumar, Ashna A., et al.
Publicado: (2022)

Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas
por: Ulisse, Salvatore, et al.
Publicado: (2010)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View
por: Alfano, Daniela, et al.
Publicado: (2022)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
por: Margheri, Francesca, et al.
Publicado: (2014)

Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells
por: Caputo, Tania Mariastella, et al.
Publicado: (2023)

Semi-quantitation of urokinase plasminogen activator and its receptor in breast carcinomas by immunocytochemistry.
por: Kennedy, S., et al.
Publicado: (1998)

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2014)

Minireview: The Epigenetic Modulation of KISS1 in Reproduction and Cancer
por: Motti, Maria Letizia, et al.
Publicado: (2019)

The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets
por: Buckley, Benjamin J., et al.
Publicado: (2019)

Role of Urokinase Receptor in Tumor Progression and Development
por: Noh, Hyangsoon, et al.
Publicado: (2013)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Expression of urokinase-type plasminogen activator, its receptor, and its inhibitor in gastric adenocarcinoma tissues.
por: Hong, S. I., et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_00a46enjf34i5lurp1da69jd01